Fook-thean Y. Lee

Heidelberg, VIC 3084, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy.

An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy.

Journal: Cancers

Published: April 03, 2024

Prognostic implication of the neoadjuvant rectal score and other biomarkers of clinical outcome in Hong Kong Chinese patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.

Prognostic implication of the neoadjuvant rectal score and other biomarkers of clinical outcome in Hong Kong Chinese patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi

Published: June 06, 2022

Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours.

Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours.

Journal: Cancers

Published: May 02, 2022

Fast-track versus traditional perioperative care for laparoscopic colorectal surgery: a prospective randomised trial (abridged secondary publication).

Fast-track versus traditional perioperative care for laparoscopic colorectal surgery: a prospective randomised trial (abridged secondary publication).

Journal: Hong Kong medical journal = Xianggang yi xue za zhi

Published: January 28, 2021

First clinical study of a pegylated diabody 124I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers.

First clinical study of a pegylated diabody 124I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers.

Journal: Theranostics

Published: June 12, 2020

Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a.

Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a.

Journal: Theranostics

Published: February 15, 2018

In Vitro and In Vivo Evaluation of 89Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 Therapy.

In Vitro and In Vivo Evaluation of 89Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 Therapy.

Journal: Theranostics

Published: May 23, 2016

Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers.

Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers.

Journal: EJNMMI research

Published: January 26, 2016

Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a.

Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 16, 2015

Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer.

Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 01, 2015

Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment.

Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment.

Journal: Cancer research

Published: August 16, 2014

Targeted chemoradiation in metastatic colorectal cancer: a phase I trial of 131I-huA33 with concurrent capecitabine.

Targeted chemoradiation in metastatic colorectal cancer: a phase I trial of 131I-huA33 with concurrent capecitabine.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 22, 2014

Showing 1-12 of 30

Last Updated: 09/26/2026